Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LXEO

Lexeo Therapeutics, Inc.

CIK 0001907108 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$5.05
↓ 0.23 (-4.36%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Options

Key stats

Market Cap
$396.53M
P/E Ratio
-4.53
EPS
-1.86
Dividend Yield
Not covered
52W Position
20%
Beta
1.81

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.71
P/S
Not covered
EV/Revenue
Not covered
ROE
-37.8%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 20%
$3.60$10.99

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$99.96M
Total Assets
$268.69M
Free Cash Flow
-$98.96M

Recent news